aTYR PHARMA INC (ATYR) Free cash flow 2016–2025
aTYR PHARMA INC (ATYR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$62.1MFY2025 · since FY2016: -$53.5M → -$62.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.1M | +10.3% |
| FY2024 | -$69.2M | -84.8% |
| FY2023 | -$37.4M | +14.0% |
| FY2022 | -$43.5M | -30.8% |
| FY2021 | -$33.3M | -114.6% |
| FY2020 | -$15.5M | +22.8% |
| FY2019 | -$20.1M | +36.5% |
| FY2018 | -$31.7M | +27.5% |
| FY2017 | -$43.7M | +18.3% |
| FY2016 | -$53.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Net marginATYR Gross profitATYR Gross marginATYR Operating incomeATYR Operating marginATYR Operating cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Total liabilitiesATYR Shareholders’ equityATYR overview →